Tue, March 5, 2019
Mon, March 4, 2019
Fri, March 1, 2019
Thu, February 28, 2019
Wed, February 27, 2019
Tue, February 26, 2019
Mon, February 25, 2019
Fri, February 22, 2019
Thu, February 21, 2019
Wed, February 20, 2019
Tue, February 19, 2019
Fri, February 15, 2019
Thu, February 14, 2019
Wed, February 13, 2019
Tue, February 12, 2019
Mon, February 11, 2019
Fri, February 8, 2019
Thu, February 7, 2019
Wed, February 6, 2019
Tue, February 5, 2019
Mon, February 4, 2019
Fri, February 1, 2019
Thu, January 31, 2019
Wed, January 30, 2019
Tue, January 29, 2019
Mon, January 28, 2019

Thomas Shrader Downgraded (BIIB) to Hold and Decreased Target to $346 on, Feb 21st, 2019


  Copy link into your clipboard //stocks-investing.news-articles.net/content/201 .. nd-decreased-target-to-346-on-feb-21st-2019.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI


Thomas Shrader of Stifel, Downgraded "Biogen Inc." (BIIB) to Hold and Decreased Target from $397 to $346 on, Feb 21st, 2019.

Thomas has made no other calls on BIIB in the last 4 months.



There are 2 other peers that have a rating on BIIB. Out of the 2 peers that are also analyzing BIIB, 0 agree with Thomas's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Thomas


  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $401 on, Wednesday, December 19th, 2018
  • Cory Kasimov of "JP Morgan" Maintained at Buy with Decreased Target to $436 on, Wednesday, October 24th, 2018

Publication Contributing Sources